Depression, anxiety, and daytime sleepiness among type 2 diabetic patients and their correlation with the diabetes control: A case-control study
Abstract
Abstract Objectives Diabetes mellitus, depression, and excessive daytime sleepiness (EDS) are common health disorders that are associated with significant mortality and morbidity. When observed together, these disorders precipitate the other's deleterious effects. In this study, we aimed to study depression, anxiety, EDS, and their relation with diabetes control among patients with type 2 diabetes mellitus in Tabuk, KSA. Methods This case-control study was conducted in a diabetes centre in Tabuk during March to June 2015. One hundred and seventy-eight diabetic and one hundred control patients signed a written informed consent. These participants were then interviewed using the Arabic versions of Beck Depression Inventory (BDI), Epworth Sleepiness Scale (ESS), and Hamilton Anxiety Scale (HAS). The Statistical Package for Social Sciences (SPSS) was used for data analysis. Results Depression was evident in 61.8% of diabetic patients vs. 30% in controls. EDS was found in 6.7% of diabetic patients and was not reported in controls (P-value Conclusion In this study, depression and EDS were common among diabetic patients, although there was no difference with the prevalence of anxiety between diabetic and control patients. In addition, no differences were found between patients with poor diabetes control and those who attempted to control their depression, EDS, and anxiety.
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.